(Reuters) - WASHINGTON, April 16 - Earlier use of Bristol-Myers Squibb Co.'s Availed to treat certain hypertension patients should win US approval, a Food and Drug Administration reviewer said in documents released on Monday.
The drug, first approved in 1997, is already approved to treat hypertension after use of either irbesartan or hydrochlorothiazide fails to help reach desired blood pressure levels.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment